ReviewArchives of microbiology2026
Clade-specific evolution and genome plasticity underlying antimicrobial resistance in Enterococcus faecium.
Review in Archives of microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A commensal organism has transformed into the leading multidrug resistant (MDR) hospital acquired pathogen, with serious implication on global public health. The ability of Enterococcus faecium to rapidly adapt through its great genomic plasticity, horizontal gene transfer and under selective pressures created by heavy antibiotic application both clinically and non-clinically is responsible for the phenomenon. Comparative genome studies have reported the presence of different community acquired and hospital acquired clades; hospital acquired clones being particularly the clonal complex 17 have enriched antibiotic resistant genes, mobile genetic elements, virulence factors. Therapeutic choices are now restricted, while mortality and morbidity increase due to lack of adequate drug targets, resistant to penicillin, vancomycin, linezolid and daptomycin. This review critically discuss the finding about the evolutionary history, diversity of genome, resistant mechanisms and global resistant trends of E. faecium's evolution into the hospital associated strain. The clinical and public health importance of MDR E. faecium is reviewed within the context of one health including the integrated roles of human, animal, and environment as reservoirs. Lastly, the review highlights the importance of integrated genomic surveillance, novel therapy approaches and an enhanced antimicrobial stewardship program according to World Health Organization priorities in the global fight against MDR E. faecium.
Indexed as
Identifiers
42579153What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.